PennTex Midstream Partners, LP to Participate in Barclays MLP Corporate Access Day
Feb 29, 2016 13:00 pm UTC| Business
HOUSTON, Feb. 29, 2016 -- PennTex Midstream Partners, LP (NASDAQ:PTXP) (the “Partnership”) announced today that members of the Partnership’s management team will participate in the Barclays MLP Corporate Access Day. The...
Feb 29, 2016 13:00 pm UTC| Business
HOUSTON, Feb. 29, 2016 -- SAExploration Holdings, Inc. (NASDAQ:SAEX) (OTCBB:SAEXW) today announced plans to release its consolidated financial results for the fourth quarter and fiscal year ended December 31, 2015 on...
Atara Bio to Present at the Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 29, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that...
Feb 29, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 29, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Natural Health Trends Corp. (“Natural Health Trends” or the “Company”)(NASDAQ:NHTC) and certain of its officers. The...
Chiasma Joins Patient Organizations Worldwide in Support of Rare Disease Day
Feb 29, 2016 13:00 pm UTC| Business
NEWTON, Mass., Feb. 29, 2016 -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical company, today announced its support for Rare Disease Day 2016. In honor of Rare Disease Day, President and Chief Executive...
TubeMogul Program to Provide Automatic Refunds for Non-Human Traffic
Feb 29, 2016 13:00 pm UTC| Business
EMERYVILLE, Calif., Feb. 29, 2016 -- Today, TubeMogul (NASDAQ:TUBE), an enterprise software company for brand advertising, announced the launch of its Non-Human Traffic Credit Program. Available to platform clients that...
Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
Feb 29, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 29, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...